1. Home
  2. DRS vs HALO Comparison

DRS vs HALO Comparison

Compare DRS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leonardo DRS Inc.

DRS

Leonardo DRS Inc.

HOLD

Current Price

$34.72

Market Cap

8.8B

Sector

Industrials

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.36

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRS
HALO
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DRS
HALO
Price
$34.72
$68.36
Analyst Decision
Strong Buy
Buy
Analyst Count
6
12
Target Price
$46.83
$73.33
AVG Volume (30 Days)
866.8K
2.6M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
1.03%
N/A
EPS Growth
33.93
56.68
EPS
0.99
4.74
Revenue
$3,569,000,000.00
$1,242,852,000.00
Revenue This Year
$11.94
$34.83
Revenue Next Year
$6.66
$24.84
P/E Ratio
$35.14
$14.39
Revenue Growth
12.27
31.19
52 Week Low
$28.17
$46.26
52 Week High
$49.31
$79.50

Technical Indicators

Market Signals
Indicator
DRS
HALO
Relative Strength Index (RSI) 52.63 56.82
Support Level $32.43 $61.23
Resistance Level $33.57 $66.60
Average True Range (ATR) 0.90 2.08
MACD 0.22 0.48
Stochastic Oscillator 91.41 86.10

Price Performance

Historical Comparison
DRS
HALO

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: